Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

For all their long history in vaccines, GSK and Sanofi have struggled to get a shot for COVID-19 authorised ... Beta variant of SARS-CoV-2 – as a booster vaccine candidate on the back ...

Yes, older Americans should get yet another COVID shot—but if you have already gotten the latest version, there's no rush.

Sanofi has said that it won't develop its mRNA-based vaccine for COVID-19 any further ... programme to include a study of the shot as a booster dose. On the positive side – given Sanofi's ...

Sanofi and GSK also noted a strong immune response after a single shot in participants who had previously contracted the coronavirus, suggesting the vaccine could find success as a booster.

Fewer health care workers are getting the most recent COVID-19 booster. Findings from a new survey by the Centers for Disease ...

First thing I want to say is, you definitely should get the first booster. And that's for everyone 12 and older six months after completing their COVID-19 vaccine primary series. Now, more than ...

Part of the global response strategy against the COVID pandemic involves the administration of booster shots ... BNL received consulting fees from Sanofi and GSK and holds stock options from ...

Sales of Covid booster shots have cratered this year ... While Moderna represents a concentrated bet on vaccines, Pfizer, GSK (GSK), and Sanofi (SNY)—leading vaccine makers in the U.S.—are huge, ...

Kennedy, known as a persistent critic of vaccine safety and a booster of conspiracy theories, said it is a possibility he ...

During the Covid-19 pandemic, the French government made pledges to restore self-sufficiency in healthcare. Labour unions last week called for strike action at Sanofi's plants in France over fears ...